Microcap Ledger Hyperfine, Inc. $HYPR
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- Guilford, CT
- Fiscal year end
- December 31
What the company doesAI summary of filing
Hyperfine develops and commercializes the Swoop® Portable MR Imaging System, an FDA-cleared, portable ultra-low-field magnetic resonance imaging device for brain imaging that operates at significantly lower magnetic field strength than conventional MRI scanners. The company generates revenue by selling the Swoop® system along with annual software, service and support agreements, and is expanding commercially across U.S. hospitals (critical care units, emergency departments, and hospital-based clinics), U.S. office-based neurology practices, and international markets through distributor relationships. Hyperfine is a revenue-generating company that has received multiple FDA clearances since its initial 2020 clearance, most recently for its eleventh-generation AI-powered software in December 2025, and holds a portfolio of 197 issued patents worldwide. [10-K 2026-03-18]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $7.81M | −$17.92M | −$16.28M | $43.46M | [10-Q 2026-08-06] |
| FY ended Dec 2025 | $13.56M | −$35.57M | −$27.95M | $35.09M | [10-K 2026-03-18] |
| FY ended Dec 2024 | $12.89M | −$40.72M | −$38.77M | $37.65M | [10-K 2026-03-18] |
- Quarterly cash burn
- −$8.14M
- Cash runway Estimate
- ~16 months
Capital structure and dilution
- Shelf registration
- S-3 filed 2026-05-12; declared effective 2026-05-21 [S-3 2026-05-12]
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-09-18. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-09-18 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-09-18] |
| 2025-05-02 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-05-02] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-24 | Teisseyre Thomas | sell | 7,345 | $0.85 | [4 2026-08-25] |
| 2026-08-24 | Hale Brett | sell | 7,345 | $0.85 | [4 2026-08-25] |
| 2026-05-26 | Hale Brett | sell | 6,047 | $1.65 | [4 2026-05-27] |
| 2026-05-26 | Teisseyre Thomas | sell | 6,047 | $1.65 | [4 2026-05-27] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-08 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-09-18 | 8-K | Listing notice or transfer |
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Results of operations |
| 2026-07-28 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-05-21 | 8-K | Shareholder vote results |
| 2026-05-12 | S-3 | Registration statement |
| 2026-05-12 | 10-Q | Quarterly report |
| 2026-05-12 | 8-K | Results of operations |
| 2026-04-08 | DEF 14A | Proxy statement |
| 2026-03-18 | 10-K | Annual report |
| 2026-03-18 | 8-K | Material agreement entered; New financial obligation; Unregistered sale of equity |
Alerts for $HYPR
Email me when Hyperfine, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.